about
Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionNew-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies.Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity or mortality? No.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cardiovascular effects of the thiazolidinediones.
@ast
Cardiovascular effects of the thiazolidinediones.
@en
type
label
Cardiovascular effects of the thiazolidinediones.
@ast
Cardiovascular effects of the thiazolidinediones.
@en
prefLabel
Cardiovascular effects of the thiazolidinediones.
@ast
Cardiovascular effects of the thiazolidinediones.
@en
P2860
P356
P1476
Cardiovascular effects of the thiazolidinediones
@en
P2093
Peter Schulman
P2860
P356
10.1002/DMRR.596
P50
P577
2006-03-01T00:00:00Z